Oncology & Cancer
Possible association for bortezomib therapy, chalazia
(HealthDay)—There is a possible correlation between bortezomib use and chalazia, according to a report published online Oct. 15 in JAMA Ophthalmology.
Oct 19, 2015
0
6
News tagged with bortezomib
Oncology & Cancer
Low dose of targeted drug might improve cancer-killing virus therapy
Giving low doses of a particular targeted agent with a cancer-killing virus might improve the effectiveness of the virus as a treatment for cancer, according to a study led by researchers at The Ohio State University Comprehensive ...
Jun 16, 2014
0
1
Oncology & Cancer
Cancer drug boosts levels of vascular-protective gene, KLF2
Case Western Reserve University researchers have discovered that an existing drug used to help cancer patients has the potential to protect thousands of others from the often-deadly impact of vascular clots.
Jun 12, 2014
0
0
Oncology & Cancer
Novel drug regimen can improve stem cell transplantation outcomes
Adding bortezomib (Velcade) to standard preventive therapy for graft-versus-host-disease (GVHD) results in improved outcomes for patients receiving stem-cell transplants from mismatched and unrelated donors, according to ...
Dec 8, 2013
0
0
Oncology & Cancer
Research team uncovers root cause of multiple myeloma relapse
Researchers have discovered why multiple myeloma, a difficult to cure cancer of the bone marrow, frequently recurs after an initially effective treatment that can keep the disease at bay for up to several years.
Sep 18, 2013
0
0
Oncology & Cancer
Aggressive breast cancers may be sensitive to drugs clogging their waste disposal
In a new paper in Cancer Cell, a team led by Judy Lieberman, PhD, of Boston Children's Hospital's Program in Cellular and Molecular Medicine reports "triple-negative" breast cancers may be vulnerable to drugs that attack ...
Aug 12, 2013
0
0
Oncology & Cancer
Medication duloxetine helps reduce pain from chemotherapy
Among patients with painful chemotherapy-induced peripheral neuropathy, use of the anti-depressant drug duloxetine for 5 weeks resulted in a greater reduction in pain compared with placebo, according to a study in the April ...
Apr 2, 2013
0
0
Oncology & Cancer
New compound holds high promise in battling kidney cancer
Chemists at the University of California, Riverside have developed a compound that holds much promise in the laboratory in fighting renal (kidney) cancer.
Feb 19, 2013
0
0
Oncology & Cancer
Possible new therapy for the treatment of myeloma
(Medical Xpress)—Research from Karolinska Institutet shows that sorafenib, a drug used for advanced cancer of the kidneys and liver, could also be effective against multiple myeloma. The disease is one of the more common ...
Sep 5, 2012
0
0
Oncology & Cancer
Bortezomib beneficial in graft-versus-host disease prophylaxis
(HealthDay) -- Patients with hematologic malignancies undergoing an HLA-mismatched unrelated donor (MMUD) reduced-intensity conditioning (RIC) hematopoietic stem cell transplantation (HSCT) may benefit from a prophylactic, ...
Aug 8, 2012
0
0
